Cargando…
Targeting the radiation-induced ARv7-mediated circNHS/miR-512-5p/XRCC5 signaling with Quercetin increases prostate cancer radiosensitivity
BACKGROUND: Radiation therapy (RT) with androgen deprivation therapy (ADT) is an effective therapy to suppress the locally advanced prostate cancer (PCa). However, we unexpectedly found that RT could also induce the androgen receptor splice variant 7 (ARv7) expression to decrease the radiosensitivit...
Autores principales: | Chen, Dong, Chou, Fu-Ju, Chen, Yuhchyau, Huang, Chi-Ping, Tian, Hao, Wang, Yaqin, Niu, Yuanjie, You, Bosen, Yeh, Shuyuan, Xing, Nianzeng, Chang, Chawnshang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347162/ https://www.ncbi.nlm.nih.gov/pubmed/35918767 http://dx.doi.org/10.1186/s13046-022-02287-4 |
Ejemplares similares
-
Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer
por: Chou, Fu-Ju, et al.
Publicado: (2020) -
Computational and Spectral Investigation of 5,12-Dihydro-5,12-ethanonaphthacene-13-carbaldehyde
por: Karama, Usama, et al.
Publicado: (2011) -
5,12-Dimethylpyrazino[1,2-a:4,5-a′]dibenzimidazole-5,12-diium dichloride dihydrate
por: Han, Jie, et al.
Publicado: (2012) -
Circ_0000215 Exerts Oncogenic Function in Nasopharyngeal Carcinoma by Targeting miR-512-5p
por: Chen, Xinping, et al.
Publicado: (2021) -
Preclinical Study Using ABT263 to Increase Enzalutamide Sensitivity to Suppress Prostate Cancer Progression Via Targeting BCL2/ROS/USP26 Axis Through Altering ARv7 Protein Degradation
por: Xu, Hua, et al.
Publicado: (2020)